Guided Therapeutics IncOTCQB:GTHP
- LAST PRICE0.0995
- TODAY'S CHANGE (%)0.0000 (0.0000%)
- Bid / Lots---/ ---
- Ask / Lots---/ ---
- Open / Previous Close0.0000 / 0.0995
- Day Range---
- 52 Week Range
- Volume2
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Guided Therapeutics Inc | 5.5M | -1.3x | --- |
Heart Test Laboratories Inc | 7.1M | -0.2x | --- |
Catheter Precision Inc | 3.6M | 0.0x | --- |
Helius Medical Technologies Inc | 4.5M | 0.0x | --- |
Kallo Inc | 1.9M | -2.1x | --- |
Kelyniam Global Inc | 1.5M | -2.0x | --- |
Company Information
Guided Therapeutics, Inc. is a medical technology company. The Company is focused on developing medical devices that have the potential to improve healthcare. The Company’s primary focus is the sales and marketing of its LuViva Advanced Cervical Scan non-invasive cervical cancer detection device. The underlying technology of LuViva primarily relates to the use of biophotonics for the non-invasive detection of cancers. LuViva is designed to identify cervical cancers and precancers painlessly, non-invasively and at the point of care by scanning the cervix with light, then analyzing the reflected and fluorescent light. LuViva is designed to provide a less invasive and painless alternative to conventional tests for cervical cancer screening and detection. Additionally, LuViva is designed to improve patient well-being not only because it eliminates pain, but also because it is convenient to use and provides rapid results at the point of care.
Contact Information
- Headquarters
- Suite 300, 4955 Avalon Ridge PkwyNORCROSS, GA, United States 30071
- Phone
- 770-242-8723
- Fax
- 770-242-8639
Executives
- Independent Chairman of the Board
- Michael James
- President, Chief Executive Officer, Acting Chief Financial Officer, Chief Operating Officer, Director
- Mark Faupel
- Acting Chief Financial Officer
- Gene Cartwright
- Director
- Richard Blumberg
- Director
- Alan Grujic
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $5.5M |
|---|---|
Revenue (TTM) | $98.0K |
Shares Outstanding | 55.6M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 0.39 |
EPS | $-0.07 |
Book Value | $-0.07 |
P/E Ratio | -1.3x |
Price/Sales (TTM) | 56.5 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -3,326.53% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
